Eating whole fruit lowers risk of diabetes than its juices

http://l.yimg.com/ck/image/A7104/71043/300_71043.jpg

Eating whole fresh fruit, especially blueberries, grapes, apples and pears, will lower risk of type 2 diabetes, but drinking more fruit juice has the opposite effect

Eating more whole fresh fruit, especially blueberries, grapes, apples and pears, is linked to a lower risk of type 2 diabetes, but drinking more fruit juice has the opposite effect, says a study.

British, US and Singaporean researchers pored over data from three big health investigations that took place in the United States, spanning a quarter of a century in all.

More than 187,000 nurses and other professional caregivers were enrolled.

Their health was monitored over the following years, and they regularly answered questionnaires on their eating habits, weight, smoking, physical activity and other pointers to lifestyle.

Around 6.5 percent of the volunteers developed diabetes during the studies.

People who ate at least two servings each week of certain whole fruits, especially blueberries, grapes and apples, reduced their risk of type 2 diabetes by as much as 23 percent compared to those who ate less than one serving per month.

“Our findings provide novel evidence suggesting certain fruits may be especially beneficial for lower diabetes risk,” said Qi Sun, an assistant professor of nutrition at the Harvard School of Public Health.

On the other hand, those who consumed one or more servings of fruit juice each day saw their risk of the disease increase by as much as 21 percent.

Swapping three servings of juice per week for whole fruits resulted in a seven-percent reduction in risk, although there was no such difference with strawberries and cantaloupe melon.

“Greater consumption of specific whole fruits, particularly blueberries, grapes, and apples, was significantly associated with a lower risk of type 2 diabetes, whereas greater fruit juice consumption was associated with a higher risk,” the authors say in the paper.

The paper, published on Friday by the British Medical Journal (BMJ), says further work is needed to to explore this “significant” difference.

It speculates that, even if the nutritional values of whole fruit and fruit juice are similar, the difference lies with the fact that one food is a semi-solid and the other a liquid.

“Fluids pass through the stomach to the intestine more rapidly than solids even if nutritional content is similar,” says the paper.

“For example, fruit juices lead to more rapid and larger changes in serum [blood] levels of glucose and insulin than whole fruits.”

The study also points to evidence that some kinds of fruit have a beneficial effect for health.

Berries and grapes, for instance, have compounds called anthocyanins which have been found to lower the risk of heart attacks.

But, say the authors, how or even whether this also applies to diabetes risks is for now unclear.

The investigation looked at data from the Nurses` Health Study, which ran from 1984-2008; the Nurses` Health Study II (1991-2009); and the Health Professionals Follow-Up Study (1986-2008).

Ten kinds of fruit were used in the questionnaire: grapes or raisins; peach, plums or apricots; prunes; bananas; cantaloupe melon; apples or pears; oranges; grapefruit; strawberries; and blueberries.

The fruit juices identified in the questionnaire were apple, orange, grapefruit and “other.”

Source: http://zeenews.india.com/news/health/healthy-eating/whole-fruit-deters-diabetes-juice-boosts-risk-study_23641.html


Overuse of painkillers leads to more headaches

http://i.telegraph.co.uk/multimedia/archive/02175/co-codamol_2175885b.jpg

Overuse of painkillers leads to more headaches

Health experts have warned that taking too many painkillers and other treatments for migraine attacks can lead to more headaches.

According to Professor Gillian Leng , from medicines watchdog the National Institute for Health and Care Excellence (Nice), headaches and migraine can have a very significant, negative impact on sufferers, therefore people should understand that different headaches require different treatments, the Daily Express reported.

Leng said that overusing some types of medication for treating tension-type headaches or migraines can actually make things worse, thus causing further pain.

Meanwhile, a consultant neurologist said that the effective management of headaches, which depends on making a correct diagnosis and agreeing on an appropriate treatment plan, should be taken into consideration.

Source: http://zeenews.india.com/news/health/health-news/overuse-of-painkillers-leads-to-more-headaches_23611.html


Milk samples fail to conform to standards

http://media.rbi.com.au/FM_Media_Library/ServiceLoad/Article/milk-know-about-health_1_300.jpg

Azad said penal action is taken against offenders in case the samples are found to be not conforming to the provisions of the food safety act.

More than 68 percent of milk samples tested across the country by the Food Safety and Standards Authority of India (FSSAI) failed to conform to recommended standards, parliament has been informed.
The FSSAI conducted a national survey to ascertain the quality of milk throughout the country, in which 68.4 percent samples were found to be non-conforming to food safety and standards regulations, 2011, Health Minister Ghulam Nabi Azad said Tuesday in reply to a written question in the Rajya Sabha.

The FSSAI is the nodal agency which regulates manufacture, storage, distribution, sale and import of food items.
The implementation of the Food Safety and Standards Act, 2006, rests with state governments.

Random samples of food items, including milk, are taken by the state food safety officers and sent to the designated laboratories for analysis.

Azad said penal action is taken against offenders in case the samples are found to be not conforming to the provisions of the food safety act.

The 12th five year plan has made an outlay of Rs.1, 500 crore to strengthen the food regulatory system at the state level.

Source: http://zeenews.india.com/news/health/health-news/milk-samples-fail-to-conform-to-standards_23614.html


Scientists grow “mini human brains” from stem cells

http://www.globalpost.com/sites/default/files/imagecache/gp3_small_article/brain_fibers.jpg

with human stem cells and created a culture in the lab that allowed them to grow into so-called “cerebral organoids” – or mini brains

Scientists have grown the first mini human brains in a laboratory and say their success could lead to new levels of understanding about the way brains develop and what goes wrong in disorders like schizophrenia and autism.
Researchers based in Austria started with human stem cells and created a culture in the lab that allowed them to grow into so-called “cerebral organoids” – or mini brains – that consisted of several distinct brain regions.

It is the first time that scientists have managed to replicate the development of brain tissue in three dimensions.

Using the organoids, the scientists were then able to produce a biological model of how a rare brain condition called microcephaly develops – suggesting the same technique could in future be used to model disorders like autism or schizophrenia that affect millions of people around the world.

“This study offers the promise of a major new tool for understanding the causes of major developmental disorders of the brain … as well as testing possible treatments,” said Paul Matthews, a professor of clinical neuroscience at Imperial College London, who was not involved in the research but was impressed with its results.
Zameel Cader, a consultant neurologist at Britain`s John Radcliffe Hospital in Oxford, described the work as “fascinating and exciting”. He said it extended the possibility of stem cell technologies for understanding brain development and disease mechanisms – and for discovering new drugs.
Although it starts as relatively simple tissue, the human brain swiftly develops into the most complex known natural structure, and scientists are largely in the dark about how that happens.

This makes it extremely difficult for researchers to gain an understanding of what might be going wrong in – and therefore how to treat – many common disorders of the brain such as depression, schizophrenia and autism.

GROWING STEM CELLS

To create their brain tissue, Juergen Knoblich and Madeline Lancaster at Austria`s Institute of Molecular Biotechnology and fellow researchers at Britain`s Edinburgh University Human Genetics Unit began with human stem cells and grew them with a special combination of nutrients designed to capitalize on the cells` innate ability to organize into complex organ structures.
They grew tissue called neuro ectoderm – the layer of cells in the embryo from which all components of the brain and nervous system develop.

Fragments of this tissue were then embedded in a scaffold and put into a spinning bioreactor – a system that circulates oxygen and nutrients to allow them to grow into cerebral organoids.

After a month, the fragments had organized themselves into primitive structures that could be recognized as developing brain regions such as retina, choroid plexus and cerebral cortex, the researchers explained in a telephone briefing.
At two months, the organoids reached a maximum size of around 4 millimeters (0.16 inches), they said. Although they were very small and still a long way from resembling anything like the detailed structure of a fully developed human brain, they did contain firing neurons and distinct types of neural tissue.

“This is one of the cases where size doesn`t really matter,” Knoblich told reporters.

“Our system is not optimized for generation of an entire brain and that was not at all our goal. Our major goal was to analyze the development of human brain (tissue) and generate a model system we can use to transfer knowledge from animal models to a human setting.”
In an early sign of how such mini brains may be useful for studying disease in the future, Knoblich`s team were able to use their organoids to model the development of microcephaly, a rare neurological condition in which patients develop an abnormally small head, and identify what causes it.

Both the research team and other experts acknowledged, however, that the work was a very long way from growing a fully-functioning human brain in a laboratory.
“The human brain is the most complex thing in the known universe and has a frighteningly elaborate number of connections and interactions, both between its numerous subdivisions and the body in general,” said Dean Burnett, lecturer in psychiatry at Cardiff University.

“Saying you can replicate the workings of the brain with some tissue in a dish in the lab is like inventing the first abacus and saying you can use it to run the latest version of Microsoft Windows – there is a connection there, but we`re a long way from that sort of application yet.”

Source: http://zeenews.india.com/news/health/health-news/scientists-grow-mini-human-brains-from-stem-cells_23619.html


Bharat Biotech launches fourth generation typhoid vaccine

new vaccine brings hope to millions by protecting them against typhoid caused by salmonella typhi

Bharat Biotech, a city-based vaccine manufacturer, today announced the launch of Typbar-TCV, the world`s first clinically proven typhoid conjugate vaccine for six months old infants and adults.

Bharat Biotech CMD Krishna M Ella said the new vaccine brings hope to millions by protecting them against typhoid caused by salmonella typhi, a highly virulent and invasive enteric bacterium.

Ella said that this is a fourth generation vaccine against typhoid disease which has been proven to provide long term protection to adults and infants. Typhoid vaccines fall short in two major counts, namely long-term protection and protection of children below two years of age.

“We hope this vaccine will reach millions of people and help reduce the burden of this devastating disease in infants and children,” Ella told reporters at a press conference here, adding that his company had commenced commercial production of Typbar-TCV in pre-filled syringes at its vaccine production facility in Genome Valley.

“The pricing of the vaccine has not yet been decided. There will be two price structures. One for public institutions and the other one will be for private organizations. Pricing will be fixed by next week,” he said.
The plant has the capacity to produce 10 million doses each year, which is expandable to 50 million doses per year in future. Bharat Biotech is the largest producer and supplier of typhoid vaccine in the world, having distributed over 50 million doses globally, he claimed.

Quoting World Health Organization reports, Director-General of the International Vaccine Institute (IVI) Christian Loucq said that typhoid fever kills between 250,000 to 600,000, besides causing 20 million illnesses per year, affecting mostly school children.

“The World Health Organization reports that 90 per cent of typhoid deaths occur in Asia and persists mainly in children under five years of age. In India, typhoid fever is observed throughout the year and a greater number of cases coincide with the rainy season,” Loucq said.

While typhoid fever can be cured by antibiotics, resistance to anti-microbials is widespread along with poor diagnostics, he said, adding that hence prevention of typhoid fever is better than curing it.

Source:

http://zeenews.india.com/news/health/health-news/bharat-biotech-launches-fourth-generation-typhoid-vaccine_23585.html